Document:

EX-10.1

 Exhibit 10.1 

SECOND AMENDMENT TO AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT 

THIS SECOND AMENDMENT to Amended and Restated Loan and Security Agreement (this “Amendment”) is entered into as of
March 30, 2015 (the “Amendment Date”), by and among OXFORD FINANCE LLC, a Delaware limited liability company with an office located at 133 North Fairfax Street, Alexandria, Virginia 22314 (in its individual capacity,
“Oxford”; and in its capacity as Collateral Agent, “Collateral Agent”), the Lenders listed on Schedule 1.1 thereof from time to time including Oxford in its capacity as a Lender (each a “Lender” and
collectively, the “Lenders”) and Entellus Medical, Inc., a Delaware corporation with offices located at 3600 Holly Lane North, Suite 40, Plymouth, MN 55447 (“Borrower”). 

WHEREAS, Collateral Agent, Borrower and Lenders party thereto from time to time have entered into that certain Amended and Restated Loan and
Security Agreement, dated as of December 20, 2013 (as amended, supplemented or otherwise modified from time to time, the “Loan Agreement”) pursuant to which Lenders have provided to Borrower certain loans in accordance with the
terms and conditions thereof; and 
 WHEREAS, Borrower, Lenders and Collateral Agent desire to amend certain provisions of the Loan
Agreement as provided herein and subject to the terms and conditions set forth herein; 
 NOW, THEREFORE, in consideration of the promises,
covenants and agreements contained herein, and other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, Borrower, Lenders and Collateral Agent hereby agree as follows: 

 

	 	1.	Capitalized terms used herein but not otherwise defined shall have the respective meanings given to them in the Loan Agreement. 

  

	 	2.	Section 6.2(a)(i) of the Loan Agreement is hereby amended and restated in its entirety as follows: 

(i) (A) (1) as soon as available, but no later than forty five (45) days after the last day of each fiscal quarter of Borrower, a Borrower
prepared consolidated (and upon Collateral Agent’s request, consolidating) balance sheet, income statement and cash flow statement covering the consolidated operations of Borrower and its Subsidiaries for such quarter certified by a Responsible
Officer and in a form reasonably acceptable to Collateral Agent; provided, however, for as long as Borrower is a SEC reporting company and fulfills its obligations under Section 6.2(a)(ii) hereof, it will not be required to provide the
aforementioned financial statements for its last fiscal quarter of each year, and (2) as soon as available, but no later than forty five (45) days after the last day of each of the first two months of each fiscal quarter of Borrower, a
Borrower prepared consolidated statement of revenues of Borrower and its Subsidiaries for such month certified by a Responsible Officer and in a form reasonably acceptable to Collateral Agent; provided, however, that for each month ending after the
date when the Collateral Agent so directs Borrower, in lieu of providing the financial statements described in this clause (A), Borrower shall deliver to each Lender the financial statements described in clause (B) below. 

(B) as soon as available, but no later than thirty (30) days after the last day of each month, a company prepared consolidated and
consolidating balance sheet, income statement and cash flow statement covering the consolidated operations of Borrower and its Subsidiaries for such month certified by a Responsible Officer and in a form reasonably acceptable to Collateral Agent.

  

	 	3.	Section 6.2(b) of the Loan Agreement is hereby amended and restated in its entirety as follows: 

(b) If Borrower is obligated to deliver financial statements pursuant to Section 6.2(a)(i)(A), then concurrently with the delivery of the
financial statements specified in Section 6.2(i)(A)(1) but no later than forty-five (45) days after the last day of each fiscal quarter, Borrower shall deliver to each Lender, a duly completed Compliance Certificate signed by a Responsible
Officer; provided, however, if Borrower is obligated to deliver financial statements pursuant to Section 6.2(a)(i)(B), then concurrently with the delivery of such financial statements but no later than thirty (30) days after the last day
of each month, Borrower shall deliver to each Lender, a duly completed Compliance Certificate signed by a Responsible Officer. 

	 	4.	Exhibit C (Compliance Certificate) to the Agreement is hereby amended and restated in its entirety as set forth on Exhibit C hereto. 

 

	 	5.	Limitation of Amendment. 

  

	 	a.	The amendments and waivers set forth in Sections 2 through 4 above are effective for the purposes set forth herein and shall be limited precisely as written and shall not be deemed to (a) be a consent to any
amendment, waiver or modification of any other term or condition of any Loan Document, or (b) otherwise prejudice any right, remedy or obligation which Lenders or Borrower may now have or may have in the future under or in connection with any
Loan Document, as amended hereby. 

  

	 	b.	This Amendment shall be construed in connection with and as part of the Loan Documents and all terms, conditions, representations, warranties, covenants and agreements set forth in the Loan Documents, except as herein
amended, are hereby ratified and confirmed and shall remain in full force and effect. 

  

	 	6.	To induce Collateral Agent and Lenders to enter into this Amendment, Borrower hereby represents and warrants to Collateral Agent and Lenders as follows: 

 

	 	a.	Immediately after giving effect to this Amendment (a) the representations and warranties contained in the Loan Documents are true, accurate and complete in all material respects as of the date hereof (except to the
extent such representations and warranties relate to an earlier date, in which case they are true and correct as of such date), and (b) no Event of Default has occurred and is continuing; 

 

	 	b.	Borrower has the power and due authority to execute and deliver this Amendment and to perform its obligations under the Loan Agreement, as amended by this Amendment; 

 

	 	c.	The organizational documents of Borrower delivered to Collateral Agent on the Effective Date, and updated pursuant to subsequent deliveries by the Borrower to the Collateral Agent, remain true, accurate and complete and
have not been amended, supplemented or restated and are and continue to be in full force and effect; 

  

	 	d.	The execution and delivery by Borrower of this Amendment and the performance by Borrower of its obligations under the Loan Agreement, as amended by this Amendment, do not and will not contravene (i) any law or
regulation binding on or affecting Borrower, (ii) any contractual restriction with a Person binding on Borrower, (iii) any order, judgment or decree of any court or other governmental or public body or authority, or subdivision thereof,
binding on Borrower, or (iv) the organizational documents of Borrower; 

  

	 	e.	The execution and delivery by Borrower of this Amendment and the performance by Borrower of its obligations under the Loan Agreement, as amended by this Amendment, do not require any order, consent, approval, license,
authorization or validation of, or filing, recording or registration with, or exemption by any governmental or public body or authority, or subdivision thereof, binding on Borrower, except as already has been obtained or made; and 

 

	 	f.	This Amendment has been duly executed and delivered by Borrower and is the binding obligation of Borrower, enforceable against Borrower in accordance with its terms, except as such enforceability may be limited by
bankruptcy, insolvency, reorganization, liquidation, moratorium or other similar laws of general application and equitable principles relating to or affecting creditors’ rights. 

  
 2 

	 	7.	Except as expressly set forth herein, the Loan Agreement shall continue in full force and effect without alteration or amendment. This Amendment and the Loan Documents represent the entire agreement about this subject
matter and supersede prior negotiations or agreements. 

  

	 	8.	This Amendment shall be deemed effective as of the Amendment Date upon (a) the due execution and delivery to Collateral Agent of this Amendment by each party hereto and (b) Borrower’s payment of all
Lenders’ Expenses incurred through the date hereof, which may be debited from any of Borrower’s accounts with Lenders. 

  

	 	9.	This Amendment may be executed in any number of counterparts, each of which shall be deemed an original, and all of which, taken together, shall constitute one and the same instrument. 

 

	 	10.	This Amendment and the rights and obligations of the parties hereto shall be governed by and construed in accordance with the laws of the State of New York. 

[Balance of Page Intentionally Left Blank] 

  
 3 

 IN WITNESS WHEREOF, the parties hereto have caused this Second Amendment to Amended and
Restated Loan and Security Agreement to be executed as of the date first set forth above. 
  

			
	BORROWER:
	
	ENTELLUS MEDICAL, INC.
		
	By		 /s/ Thomas E. Griffin

	Name:		Thomas E. Griffin
	Title:		Chief Financial Officer
	
	COLLATERAL AGENT AND LENDER:
	
	OXFORD FINANCE LLC
		
	By		 /s/ Timothy A. Lux

	Name:		Timothy A. Lux
	Title:		Chief Operating Officer

 EXHIBIT C  

Compliance Certificate 
  

			
	TO:	  	OXFORD FINANCE LLC, as Collateral Agent and Lender
		
	FROM:	  	ENTELLUS MEDICAL, INC.

 The undersigned authorized officer (“Officer”) of Entellus Medical, Inc.
(“Borrower”), hereby certifies that in accordance with the terms and conditions of the Amended and Restated Loan and Security Agreement by and among Borrower, Collateral Agent, and the Lenders from time to time party thereto (the
“Loan Agreement;” capitalized terms used but not otherwise defined herein shall have the meanings given them in the Loan Agreement), 

(a) Borrower is in complete compliance for the period ending
                     with all required covenants except as noted below; 

(b) There are no Events of Default, except as noted below; 

(c) Except as noted below, all representations and warranties of Borrower stated in Section 5 of the Loan Documents are true and correct
in all material respects on this date and for the period described in (a), above; provided, however, that such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by materiality
in the text thereof; and provided, further that those representations and warranties expressly referring to a specific date shall be true, accurate and complete in all material respects as of such date. 

(d) Borrower, and each of Borrower’s Subsidiaries, has timely filed all required tax returns and reports (or extensions if applicable),
Borrower, and each of Borrower’s Subsidiaries, has timely paid all foreign, federal, state, and local taxes, assessments, deposits and contributions owed by Borrower, or Subsidiary, except as otherwise permitted pursuant to the terms of
Section 5.8 of the Loan Agreement; 
 (e) No Liens have been levied or claims made against Borrower or any of its Subsidiaries relating
to unpaid employee payroll or benefits of which Borrower has not previously provided written notification to Collateral Agent and the Lenders. 

Attached are the required documents, if any, supporting our certification(s). The Officer, on behalf of Borrower, further certifies that the
attached financial statements are prepared in accordance with Generally Accepted Accounting Principles (GAAP) and are consistently applied from one period to the next except as explained in an accompanying letter or footnotes and except, in the case
of unaudited financial statements, for the absence of footnotes and subject to year-end audit adjustments as to the interim financial statements. 

Please indicate compliance status since the last Compliance Certificate by circling Yes, No, or N/A under “Complies” column. 

 

													
	 	  	Reporting Covenant	  	Requirement	    	Actual	    	Complies
							
	1)	  	Revenue statements	  	Monthly within 45 days	    		    	Yes	    	No	    	N/A
							
	2)	  	Financial statements	  	Quarterly within 45 days (or Monthly within 30 days if requested by Collateral Agent)	    		    	Yes	    	No	    	N/A
							
	3)	  	Annual (CPA Audited) statements	  	Within 120 days after FYE	    		    	Yes	    	No	    	N/A
							
	4)	  	Annual Financial Projections/Budget (prepared on a monthly basis)	  	Annually (within 45 days of FYE), and when revised	    		    	Yes	    	No	    	N/A

													
	5)	  	A/R & A/P agings	  	If applicable	    		    	Yes	    	No	    	N/A
							
	6)	  	8-K, 10-K and 10-Q Filings	  	If applicable, within 5 days of filing	    		    	Yes	    	No	    	N/A
							
	7)	  	Compliance Certificate	  	Quarterly within 45 days or monthly within 30 days, as applicable	    		    	Yes	    	No	    	N/A
							
	8)	  	IP Report	  	When required	    		    	Yes	    	No	    	N/A
							
	9)	  	Total amount of Borrower’s cash and cash equivalents at the last day of the measurement period	  		    	$            	    	Yes	    	No	    	N/A
							
	10)	  	Total amount of Borrower’s Subsidiaries’ cash and cash equivalents at the last day of the measurement period	  		    	$            	    	Yes	    	No	    	N/A

 Deposit and Securities Accounts 

(Please list all accounts; attach separate sheet if additional space needed) 

 

													
	 	  	Institution Name	    	Account Number	    	New Account?	  	Account Control Agreement in place?
							
	1)	  		    		    	Yes	    	No	  	Yes	  	No
							
	2)	  		    		    	Yes	    	No	  	Yes	  	No
							
	3)	  		    		    	Yes	    	No	  	Yes	  	No
							
	4)	  		    		    	Yes	    	No	  	Yes	  	No

 Other Matters 
  

							
	1)	  	Have there been any changes in management since the last Compliance Certificate?	  	Yes	  	No
				
	2)	  	Have there been any transfers/sales/disposals/retirement of Collateral or IP prohibited by the Loan Agreement?	  	Yes	  	No
				
	3)	  	Have there been any new or pending claims or causes of action against Borrower that involve more than Two Hundred Fifty Thousand Dollars ($250,000.00)?	  	Yes	  	No
				
	4)	  	Have there been any amendments of or other changes to the capitalization table of Borrower and to the Operating Documents of Borrower or any of its Subsidiaries? If yes, provide copies of any such amendments or changes with this
Compliance Certificate.	  	Yes	  	No
				
	5)	  	Have there been any registrations of any copyright, including any subsequent ownership right of Borrower or any of its Subsidiaries in or to any copyright, patent or trademark since the end of the last calendar quarter? Borrower
needs to make this certification only if this Compliance Certificate is for the last month of a calendar quarter.	  	Yes	  	No

 Exceptions 

Please explain any exceptions with respect to the certification above: (If no exceptions exist, state “No exceptions.” Attach separate sheet if
additional space needed. If this Compliance Certificate is for the last month of a calendar quarter, for any registrations of any copyright, including any subsequent ownership right of Borrower or any of its Subsidiaries in or to any copyright,
patent or trademark since the end of the last calendar quarter, please also provide copies of such registrations if requested by Lender.) 
  

			
	Entellus Medical, Inc.
		
	By:		  

	Name:		  

	Title:		  

		
	Date:		

  

									
			LENDER USE ONLY
					
			Received by:		  
		Date:		  

					
			Verified by:		  
		Date:		  

		
			Compliance Status:            Yes                    
NoExhibit 4.3

 

SECOND AMENDMENT TO THE

AVIV REIT, INC.

2010 MANAGEMENT INCENTIVE PLAN

 

WHEREAS, Aviv REIT, Inc.
(“Aviv REIT”) maintains the Aviv REIT, Inc. 2010 Management Incentive Plan (“Plan”);

 

WHEREAS, Aviv REIT, Aviv
Healthcare Properties Limited Partnership, Omega Healthcare Investors, Inc. (“Omega”), OHI Healthcare Properties
Holdco, Inc. (“Merger Sub”), and OHI Healthcare Property Limited Partnership, L.P. entered into that certain
Agreement and Plan of Merger, dated October 30, 2014 (“Merger Agreement”), providing for, among other things,
the merger of Aviv REIT into Merger Sub (“Merger”);

 

WHEREAS, under the terms
of the Merger Agreement, Omega agreed to (1) assume the Plan from Aviv REIT and (2) convert the shares of Aviv REIT common stock
underlying the outstanding awards granted under the Plan to shares of Omega common stock, contingent upon the closing of the Merger
(“Closing”) and effective as of the “Merger Effective Time” (as defined in the Merger Agreement);
and

 

WHEREAS, contingent upon
the Closing and effective as of the Merger Effective Time, Omega desires to amend the Plan to reflect (i) the assumption of the
Plan by Omega from Aviv REIT; (ii) the conversion of the shares of Aviv REIT common stock underlying the outstanding awards granted
under the Plan to shares of Omega common stock; and (iii) the termination of the Plan, provided that outstanding options under
the Plan as of the Closing Date shall not be affected by the Plan’s termination and shall remain in effect until cancelled,
forfeited, terminated or settled in accordance with the terms of the Plan and the applicable option agreements as modified by resolutions
of Omega’s Board of Directors implementing Section 2.4 of the Merger Agreement.

 

NOW, THEREFORE, contingent
upon the Closing and effective as of the Merger Effective Time, the Plan is hereby amended as follows:

 

1.             Section 1.1 of the
Plan is hereby deleted in its entirety and replaced with the following:

 

“The Aviv REIT,
Inc. 2010 Management Incentive Plan (this ‘Plan’) was previously maintained by Aviv REIT, Inc. (‘Aviv
REIT’) with the purpose of the Plan being (i) to align the interests of Aviv REIT’s stockholders and the recipients
of awards under the Plan by increasing the proprietary interest of such recipients in the Aviv REIT’s growth and success,
(ii) to advance the interests of Aviv REIT by attracting and retaining Directors and employees and consultants of AAM and its Affiliates
and (iii) to motivate such persons to act in the long-term best interests of Aviv REIT and its stockholders.

 

Effective October
30, 2014, Omega Healthcare Investors, Inc. (‘Omega’), Aviv REIT, Aviv Healthcare Properties Limited Partnership,
OHI Healthcare Properties Holdco, Inc. (‘OHI Holdco’), and OHI Healthcare Property Limited

 

    	 

    	 

    

  

Partnership, L.P.
entered into that certain Agreement and Plan of Merger, dated October 30, 2014 (‘Merger Agreement’), providing
for, among other things, the merger of Aviv REIT into OHI Holdco (‘Merger’). In accordance with the terms of
the Merger Agreement and effective as of the date of the closing of the Merger (‘Closing Date’), Aviv REIT assigned
the Plan to Omega and, pursuant to resolutions adopted by Omega’s Board of Directors Omega, assumed the Plan and, for outstanding
Options under the Plan, substituted Omega common stock for common stock of Aviv REIT using an exchange ratio of nine-tenths (0.90)
of a share of common stock of Omega for one (1) share of common stock of Aviv REIT. Pursuant to resolutions adopted by Omega’s
Board of Directors, simultaneously with Omega’s assumption of the Plan, Omega terminated the Plan, provided that outstanding
Options under the Plan as of the Closing Date will not, without the Option holder’s consent be affected by the Plan’s
termination and will remain in effect until cancelled, forfeited, terminated or settled in accordance with the terms of the Plan
and the applicable Option agreements as modified by resolutions of Omega’s Board of Directors implementing Section 2.4 of
the Merger Agreement. The Board resolutions described in the prior two sentences shall be deemed to have amended the Plan and all
provisions of the Plan shall be interpreted consistently with these resolutions.”

 

2.             Section 1.2 of the
Plan is hereby revised by adding the following to the end of the definition of “Administrator”:

 

“or, if so
designated by the Board in its sole discretion, the Compensation Committee of the Board of Directors of Omega.”

 

3.             Section 1.2 of the
Plan is hereby revised by deleting the definition of “Company” in its entirety and replacing it with the following:

 

“‘Company’
shall mean Omega Healthcare Investors, Inc., a Maryland corporation, or any successor thereto.”

 

4.             Section 1.2 of the
Plan is hereby revised by deleting the definition of “Common Stock” in its entirety and replacing it with the following:

 

“‘Common
Stock’ shall mean the common stock, $0.10 par value per share, of the Company.”

 

		5.	Section 3.1 of the Plan is hereby amended to add the following at the end thereof:

 

“The Plan is
hereby terminated as of the Closing Date. Notwithstanding anything herein to the contrary, no Options shall be granted under the
Plan as of or following the Closing Date.”

 

6.             Section 3.6 is hereby amended to
add the following at the end thereof:

 

“The number
of shares of Common Stock available for issuance under the Plan and the number of shares of Common Stock underlying each outstanding

 

    	 

    	 

    

  

Option is hereby adjusted by multiplying
such number of shares in effect immediately before the Merger Effective Time by 0.90 (the ‘Exchange Ratio’),
rounded down to the closest whole share. The exercise price per share of each outstanding Option shall be an amount determined
by dividing the exercise price per share in effect immediately before the Merger Effective Time by 0.90, rounded up to the closest
whole cent.”

 

Except as specifically
amended hereby, the Plan shall remain in full force and effect prior to this Second Amendment.

 

IN WITNESS WHEREOF, the
Company has caused this Second Amendment to be executed as of the 1st day of April, 2015.

 

	 	OMEGA HEALTHCARE INVESTORS, INC.
	 	 
	 	By:	/s/ C. Taylor Pickett
	 	 
	 	Name:  C. Taylor Pickett
	 	 
	 	Title:  Chief Executive Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00243-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00243-of-00352.parquet"}]]